Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma
NCT06520319
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Medullary Thyroid Carcinoma
Interventions
DRUG:
68Ga-MGS5
Sponsor
First Affiliated Hospital of Fujian Medical University